Kawaguchi Tatsuya | Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie

スポンサーリンク

概要

関連著者

もっと見る

著作論文

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
Association of SLCO1B3 Polymorphism with Intracellular Accumulation of Imatinib in Leukocytes in Patients with Chronic Myeloid Leukemia
TED-AJ03-370 Planar Measurement of Local Characteristics of Impinging Spray on Heating Plate
Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
Relationship between an effective dose of imatinib, body surface area, and trough drug levels in patients with chronic myeloid leukemia
New Insights into Molecular Pathogenesis of Bone Marrow Failure in Paroxysmal Nocturnal Hemoglobinuria
A Novel Type of Factor XI Deficiency Showing Compound Genetic Abnormalities: A Nonsense Mutation and an Impaired Transcription
Markedly high plasma erythropoietin and granulocyte-colony stimulating factor levels in patients with paroxysmal nocturnal hemoglobinuria
Sequential development of myelodysplasia and paroxysmal nocturnal hemoglobinuria in a patient with preceding aplastic anemia
Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria
T-lymphoblastic lymphoma/leukemia cells nagative for CD52 and CD59
Migration to an inflammatory site in vivo of paroxysmal nocturnal hemoglobinuria lymphocytes
Contribution of BCR-ABL-independent activation of ERK1/2 to acquired imatinib resistance in K562 chronic myeloid leukemia cells
(3-24) Application of Improved Interferometric Laser Imaging Droplet Sizing (ILIDS) System to Hollow-Cone Sprays((D-3)Diagnostics 3-Applications and Advamced Technolog)
High-Performance Liquid Chromatographic Assay for the Determination of Nilotinib in Human Plasma
The Influence of Polytypic Structures on the Solid-state ^C NMR Spectra of n-Alkanes
Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria : the AEGIS Clinical Trial
Rapid Amelioration of Hyperglycemia Facilitated by Dasatinib in a Chronic Myeloid Leukemia Patient with type 2 Diabetes Mellitus
Distinct Interaction of Nilotinib and Imatinib with P-Glycoprotein in Intracellular Accumulation and Cytotoxicity in CML Cell Line K562 Cells

もっと見る

スポンサーリンク